Human data backs FMT to improve brain functions and reduce healthcare burden


Faecal microbiota transplants (FMT) could significantly reduce hospitalisations and improve signs of cognitive impairment caused by severe liver disease, new human data suggests.

Transplantation of faecal bacteria from a healthy donor into patients that suffer from a decline in brain functions due to severe liver disease (known as hepatic encephalopathy) could improve cognitive function compared with standard of care treatment for the condition, according to data presented at The International Liver Congress 2017 in Amsterdam.

Led by Dr Jasmohan Bajaj from Virginia Commonwealth University in the USA, the team behind the trial found that the number of hospitalisations following FMT plus antibiotics was significantly less (two) compared to the standard of care arm (11).

Specifically, they said a significant reduction in hospitalisations due to recurrent hepatic encephalopathy was seen (six in the standard of care and none in the faecal transplant arm).

"Hepatic encephalopathy is a serious condition and a leading cause of re-admission to hospital due to recurrence, despite standard of care treatment," said Bajaj. "In patients with hepatic encephalopathy, a faecal transplant improves brain function more than standard of care as well as reducing the number of hospital admissions, including those for recurrent hepatic encephalopathy.”

Better than ‘standard of care’

Researchers randomised 20 men with cirrhosis who experienced recurrent episodes of hepatic encephalopathy prior to the start of the study, to treatment with lactulose and rifaximin (standard of care treatment), or, broad spectrum antibiotics for five days plus a single faecal transplant from a healthy donor along with continuing the standard of care.

The transplant was given as an enema. Patients were followed for up to 150 days after randomisation.

FMT plus antibiotic treatment was found to be well tolerated without any serious side effects. Furthermore, Bajaj and his team said the faecal transplant plus antibiotic therapy restored antibiotic-associated changes in the body's bacterial composition.

There was significant cognitive improvement in the FMT group on the Psychometric Hepatic Encephalopathy Score (PHES) and the Stroop App (another test of cognitive dysfunction) as compared to the standard of care group.

Faecal transplant also increased beneficial strains of bacteria, including Bifidobacteriaceae and Lactobacillacea, while no changes to microbiome or metabolomics were seen in the standard of care arm.

"This is the first randomised trial to show that faecal transplantation may be of benefit to patients with hepatic encephalopathy,” said d Prof Tom Karlsen from Oslo University Hospital Rikshospitalet, Norway. “The encouraging findings open new avenues of research to determine how to best manipulate the gut microbiota in patients with hepatic encephalopathy. They also show proof-of-concept for the likely beneficial impact of such interventions.”

“Faecal transplantation is an innovative and promising approach to treat this condition, and we look forward to more studies being conducted to confirm our results,” added Bajaj.

Related News

©iStock / frentusha

Danone Nutricia study backs synbiotic to ‘normalise’ microbiota after C-section

Many children with ASD often undergo increased oral antibiotic treatment during the first 3 years of life, which is thought to destabilise their gut microbiota. ©iStock/iculig

Faecal transplant may ease kids’ autism symptoms, small study suggests

Link to causality: Industry needs to up prebiotic & probiotic efforts

The findings make a compelling case for FMTs to be recognised as an effective individual treatment for C. difficile infection. ©iStock

Waste not want not: Faecal transplants effective against C.difficile infection

The study will involve 21 obese patients given a daily pill containing another individual's freeze-dried faecal matter. Image credit: / adrian825

Researchers to test faecal pill efficacy in treating obesity

The use of capsules simplifies the procedure immensely, potentially making it accessible to a greater population, say researchers.

Capsules are ‘as effective’ for faecal transplant delivery

Related Products

See more related products

Submit a comment

Your comment has been saved

Post a comment

Please note that any information that you supply is protected by our Privacy and Cookie Policy. Access to all documents and request for further information are available to all users at no costs, In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information maybe shared with the owners of that document or information.